Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bausch Health Companies Inc (NY: BHC ) 9.420 -0.080 (-0.84%) Official Closing Price Updated: 7:00 PM EST, Nov 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Bausch Health Companies Inc < Previous 1 2 3 4 5 6 7 Next > Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday November 01, 2024 Via Benzinga Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt October 26, 2024 IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders. Via Benzinga Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags October 21, 2024 S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day. Via Benzinga Topics Bankruptcy Stocks Exposures Financial Legal US Equities Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces October 14, 2024 Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb. Via Benzinga Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings July 29, 2024 The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. Via Benzinga Topics Economy Exposures Interest Rates Why Bausch Health Companies Shares Are Falling After Q1 Results May 02, 2024 Bausch Health misses Q1 EPS estimates at 59 cents, despite a revenue increase of 11%. Via Benzinga Preview: Bausch Health Companies's Earnings February 21, 2024 Via Benzinga Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? September 22, 2024 Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week. Via Benzinga Topics Economy Exposures Interest Rates Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues September 16, 2024 Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off. Via Benzinga Topics Supply Chain Exposures Supply Chain Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? September 16, 2024 Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns. Via Investor's Business Daily Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens September 04, 2024 Bank of Canada cuts key policy rate by 25 basis points to 4.25% and suggests further cuts if inflation continues to ease. Via Benzinga Topics Economy Exposures Interest Rates Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week October 30, 2023 S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Bausch Health Stock Is Jumping Today September 20, 2023 Investors appear to be shaking off their concerns about Bausch Health's CFO turnover. Via The Motley Fool Bausch Health Solvency Remains A Concerns, Analyst Downgrades Stock August 02, 2024 Bausch Health reports Q2 2024 GAAP EPS of $0.03, missing the consensus of $0.28. Revenue hits $2.403 billion, up 11% YoY. Piper Sandler downgrades BHC to Underweight with a price target of $3, citing... Via Benzinga US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday? August 01, 2024 Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market... Via Benzinga Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November August 01, 2024 After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a... Via Benzinga BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy July 24, 2024 Although Bausch Health has denied rumors that it’s on the cusp of bankruptcy, BHC stock is nevertheless suffering from skepticism. Via InvestorPlace Topics Bankruptcy Exposures Financial Legal Why Bausch health Shares Are Falling Today July 24, 2024 Bausch Health Companies Inc. (NYSE: BHC) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered by a report suggesting the company is negotiating a potential prepackaged... Via Benzinga Topics Bankruptcy Exposures Financial Legal Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 24, 2024 Via Benzinga Stocks Plummet After Tech Earnings, Manufacturing Data July 24, 2024 The Dow Jones Industrial Average is down triple digits, while the S&P 500 Index eyes its worst daily percentage drop since September 2023. Via Talk Markets Topics Stocks Exposures US Equities Why Bausch Health Companies Stock Dived by More Than 7% Today May 02, 2024 A large red number on the bottom line attracted the wrong kind of investor attention for the company. Via The Motley Fool BHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024 May 02, 2024 BHC stock results show that Bausch Health Companies missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know February 23, 2024 Via Benzinga A 'Toxic Byproduct of an Imperfect Higher Education System' — Famous Short Seller Known as 'The Assassin' Strikes Her Newest Target February 08, 2024 Fahmi Quadir, featured in the Netflix series "Dirty Money" for her success in predicting and betting on the collapse of Valeant ... Via Benzinga US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple November 02, 2023 After the Federal Reserve‘s decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick. Via Benzinga Topics Economy Exposures Interest Rates Wall Street On Track For Another Win Amid Interest Rate Buzz November 01, 2023 Wall Street is looking to extend a winning streak, as investors prepare for the Federal Reserve's latest interest rate decision. Via Talk Markets Topics Economy Exposures Interest Rates Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More October 28, 2023 The U.S. Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023 September 20, 2023 Via Benzinga Steelcase, Western Digital, Bausch Health And Other Big Stocks Moving Higher On Wednesday September 20, 2023 U.S. stocks traded mostly higher on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Why Shares of Bausch Health Companies Fell Tuesday September 19, 2023 The company announced a chief financial officer transition plan. Via The Motley Fool < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.